Ardsley Advisory Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-157,200
Closed -$12.4M 175
2020
Q3
$12.4M Buy
+157,200
New +$12.3M 2.4% 13
2018
Q3
Sell
-104,800
Closed -$6.07M 176
2018
Q2
$6.07M Buy
+104,800
New +$5.91M 0.91% 43
2016
Q4
Sell
-266,192
Closed -$15.9M 160
2016
Q3
$15.9M Buy
+266,192
New +$15.6M 2.51% 9

Other funds holding MRK

Ardsley Advisory Partners's MRK Position: Q2 2024 in Review

Ardsley Advisory Partners sold out of Merck (MRK) in Q2 2024, closing a stake of 61,000 shares — an estimated $8.05M sold.

Ardsley Advisory Partners first reported a position in MRK in Q2 2013 and held it in 21 quarters. The position peaked at $8.05M in Q1 2024. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Ardsley Advisory Partners reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Ardsley Advisory Partners sold 61,000 Merck shares in Q2 2024, an estimated $8.05M.
  • Ardsley Advisory Partners first reported a position in Merck in Q2 2013 and held it in 21 quarters.
  • Ardsley Advisory Partners's Merck position peaked at $8.05M in Q1 2024.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Ardsley Advisory Partners's 13F filing for Q2 2024, filed 14 Aug 2024.